End-of-day quote
Shanghai S.E.
23:00:00 28/04/2024 BST
|
5-day change
|
1st Jan Change
|
43.01
CNY
|
-0.67%
|
|
-0.32%
|
+7.42%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
15,713
|
27,745
|
47,897
|
39,611
|
46,074
|
43,465
|
43,465
|
-
|
Enterprise Value (EV)
1 |
15,713
|
27,132
|
46,953
|
37,992
|
43,468
|
38,490
|
37,289
|
35,532
|
P/E ratio
|
36.5
x
|
50.8
x
|
62
x
|
44.4
x
|
36.3
x
|
28.6
x
|
24.8
x
|
20.1
x
|
Yield
|
0.72%
|
0.41%
|
0.33%
|
0.54%
|
0.63%
|
1.25%
|
1.03%
|
1.26%
|
Capitalization / Revenue
|
2.27
x
|
2.7
x
|
3.64
x
|
2.58
x
|
2.32
x
|
1.79
x
|
1.58
x
|
1.26
x
|
EV / Revenue
|
2.27
x
|
2.64
x
|
3.57
x
|
2.48
x
|
2.19
x
|
1.7
x
|
1.36
x
|
1.03
x
|
EV / EBITDA
|
21.6
x
|
27
x
|
34.1
x
|
23.7
x
|
19.6
x
|
15.7
x
|
10.9
x
|
8.79
x
|
EV / FCF
|
56.4
x
|
53
x
|
-
|
-
|
-
|
9.87
x
|
15
x
|
12.5
x
|
FCF Yield
|
1.77%
|
1.89%
|
-
|
-
|
-
|
10.1%
|
6.65%
|
8%
|
Price to Book
|
3.87
x
|
6.15
x
|
9.13
x
|
5.29
x
|
5.38
x
|
4.13
x
|
3.84
x
|
3.32
x
|
Nbr of stocks (in thousands)
|
960,102
|
965,495
|
966,544
|
1,006,271
|
1,010,387
|
1,010,580
|
1,010,580
|
-
|
Reference price
2 |
16.37
|
28.74
|
49.55
|
39.36
|
45.60
|
43.01
|
43.01
|
43.01
|
Announcement Date
|
09/04/19
|
08/04/20
|
27/04/21
|
28/04/22
|
27/04/23
|
28/04/24
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
6,913
|
10,276
|
13,145
|
15,326
|
19,886
|
22,588
|
27,493
|
34,377
|
EBITDA
1 |
726.2
|
1,006
|
1,379
|
1,600
|
2,218
|
2,456
|
3,407
|
4,043
|
EBIT
1 |
578.3
|
815.5
|
1,170
|
1,339
|
1,886
|
2,055
|
2,609
|
3,286
|
Operating Margin
|
8.37%
|
7.94%
|
8.9%
|
8.74%
|
9.48%
|
9.1%
|
9.49%
|
9.56%
|
Earnings before Tax (EBT)
1 |
581.3
|
814.3
|
1,164
|
1,338
|
1,877
|
2,038
|
2,574
|
3,248
|
Net income
1 |
416.4
|
543.8
|
768.3
|
887.9
|
1,266
|
1,412
|
1,749
|
2,182
|
Net margin
|
6.02%
|
5.29%
|
5.84%
|
5.79%
|
6.36%
|
6.25%
|
6.36%
|
6.35%
|
EPS
2 |
0.4490
|
0.5659
|
0.7994
|
0.8857
|
1.257
|
1.400
|
1.731
|
2.138
|
Free Cash Flow
1 |
278.5
|
511.4
|
-
|
-
|
-
|
3,900
|
2,481
|
2,844
|
FCF margin
|
4.03%
|
4.98%
|
-
|
-
|
-
|
17.26%
|
9.02%
|
8.27%
|
FCF Conversion (EBITDA)
|
38.35%
|
50.84%
|
-
|
-
|
-
|
158.76%
|
72.81%
|
70.35%
|
FCF Conversion (Net income)
|
66.88%
|
94.06%
|
-
|
-
|
-
|
276.18%
|
141.84%
|
130.31%
|
Dividend per Share
2 |
0.1177
|
0.1177
|
0.1648
|
0.2143
|
0.2857
|
0.5000
|
0.4412
|
0.5409
|
Announcement Date
|
09/04/19
|
08/04/20
|
27/04/21
|
28/04/22
|
27/04/23
|
28/04/24
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
4,388
|
4,148
|
4,602
|
4,598
|
6,539
|
5,266
|
5,441
|
-
|
5,181
|
6,700
|
5,971
|
6,692
|
6,615
|
8,393
|
7,724
|
8,396
|
EBITDA
|
299.4
|
481.4
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
307.2
|
407.3
|
443.1
|
366.9
|
668.2
|
501.7
|
531.1
|
-
|
436.1
|
586
|
593.5
|
686
|
619.9
|
741.5
|
775.6
|
843.1
|
Operating Margin
|
7%
|
9.82%
|
9.63%
|
7.98%
|
10.22%
|
9.53%
|
9.76%
|
-
|
8.42%
|
8.75%
|
9.94%
|
10.25%
|
9.37%
|
8.83%
|
10.04%
|
10.04%
|
Earnings before Tax (EBT)
1 |
306.2
|
407.3
|
446
|
366.5
|
657.8
|
500.8
|
530.9
|
1,032
|
436.1
|
569.8
|
593.2
|
648.9
|
636
|
713.8
|
751.6
|
817
|
Net income
1 |
191.9
|
272.2
|
304.2
|
247.2
|
442
|
336.5
|
368.7
|
705.2
|
294
|
412.8
|
406.8
|
436.6
|
427.8
|
480.2
|
505.7
|
549.6
|
Net margin
|
4.37%
|
6.56%
|
6.61%
|
5.38%
|
6.76%
|
6.39%
|
6.78%
|
-
|
5.67%
|
6.16%
|
6.81%
|
6.52%
|
6.47%
|
5.72%
|
6.55%
|
6.55%
|
EPS
2 |
0.1929
|
0.2714
|
0.3000
|
0.2429
|
0.4429
|
0.3357
|
0.3643
|
-
|
0.2900
|
0.4100
|
0.4000
|
0.4240
|
0.3878
|
0.5177
|
0.5005
|
0.5440
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.3136
|
-
|
-
|
-
|
0.3943
|
Announcement Date
|
28/04/22
|
28/04/22
|
29/08/22
|
28/10/22
|
27/04/23
|
27/04/23
|
29/08/23
|
29/08/23
|
30/10/23
|
28/04/24
|
28/04/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
613
|
945
|
1,619
|
2,606
|
1,974
|
6,176
|
7,933
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
278
|
511
|
-
|
-
|
-
|
3,900
|
2,481
|
2,844
|
ROE (net income / shareholders' equity)
|
12.4%
|
12.7%
|
15.5%
|
13%
|
15.8%
|
15.4%
|
17%
|
17.5%
|
ROA (Net income/ Total Assets)
|
6.58%
|
6.38%
|
6.95%
|
5.48%
|
-
|
6.77%
|
7.5%
|
7.25%
|
Assets
1 |
6,326
|
8,521
|
11,062
|
16,190
|
-
|
21,203
|
23,322
|
30,102
|
Book Value Per Share
2 |
4.230
|
4.670
|
5.430
|
7.430
|
8.470
|
9.700
|
11.20
|
13.00
|
Cash Flow per Share
2 |
0.5300
|
1.000
|
1.380
|
2.140
|
3.880
|
4.580
|
3.110
|
3.450
|
Capex
1 |
232
|
452
|
579
|
821
|
578
|
724
|
1,053
|
899
|
Capex / Sales
|
3.36%
|
4.4%
|
4.4%
|
5.36%
|
2.91%
|
3.21%
|
3.83%
|
2.61%
|
Announcement Date
|
09/04/19
|
08/04/20
|
27/04/21
|
28/04/22
|
27/04/23
|
28/04/24
|
-
|
-
|
Last Close Price
43.01
CNY Average target price
51.41
CNY Spread / Average Target +19.53% Consensus |
1st Jan change
|
Capi.
|
---|
| +7.42% | 6.04B | | -29.67% | 10.84B | | -28.54% | 6.06B | | -11.41% | 5.86B | | -0.73% | 4.69B | | +52.19% | 4.29B | | -9.42% | 3.61B | | -13.25% | 3.33B | | -6.93% | 3.01B | | -2.36% | 2.8B |
Other Drug Retailers
|